monocrotaline has been researched along with Thrombocytopenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Czer, GT; Konopka, R; Marsh, J; Moser, KM | 1 |
Ganey, PE; Roth, RA; Sprugel, KH; Wagner, JG; White, SM | 1 |
2 other study(ies) available for monocrotaline and Thrombocytopenia
Article | Year |
---|---|
Low-dose PGI2 prevents monocrotaline-induced thromboxane production and lung injury.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Blood Cell Count; Blood Platelets; Body Water; Dogs; Epoprostenol; Hemodynamics; Hypertension, Pulmonary; Lung; Lung Injury; Monocrotaline; Pyrrolizidine Alkaloids; Thrombocytopenia; Thromboxane B2 | 1986 |
Pulmonary hypertension due to monocrotaline pyrrole is reduced by moderate thrombocytopenia.
Topics: Animals; Blood Platelets; Blood Pressure; Hypertension, Pulmonary; Immunization, Passive; L-Lactate Dehydrogenase; Male; Monocrotaline; Platelet-Derived Growth Factor; Pyrrolizidine Alkaloids; Rats; Rats, Inbred Strains; Thrombocytopenia | 1988 |